There's The Bolus! ANDA Sponsors Race To Avoid User Fee Spike
In a year defined by application surges, more than 200 ANDAs were submitted in September, the last month of fiscal year 2017, likely to avoid paying a much higher application fee instituted Oct. 1.
You may also be interested in...
By conducting a product development or pre-submission meeting, sponsors can receive a mid-review cycle meeting for a complex product ANDA.
New GDUFA program fee is high enough that sponsors may withdraw applications to reduce their fee exposure, agency estimates.
FDA's June approval total is highest of GDUFA era, but does it signal a new elevated productivity level for the generics program?